These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29089306)

  • 21. Involvement of human organic cation transporter 1 in the hepatic uptake of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel, small molecule survivin suppressant.
    Iwai M; Minematsu T; Narikawa S; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Sep; 37(9):1856-63. PubMed ID: 19520775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
    Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.
    Bosgra S; van de Steeg E; Vlaming ML; Verhoeckx KC; Huisman MT; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Dec; 65():156-66. PubMed ID: 25261337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma.
    Geier A; Macias RI; Bettinger D; Weiss J; Bantel H; Jahn D; Al-Abdulla R; Marin JJ
    Oncotarget; 2017 Feb; 8(9):15846-15857. PubMed ID: 28178663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions.
    Zamek-Gliszczynski MJ; Giacomini KM; Zhang L
    Clin Pharmacol Ther; 2018 May; 103(5):758-760. PubMed ID: 29193038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
    Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
    Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of hepatic organic cation transporter 1 and hepatic distribution of metformin in high-fat diet-induced obese mice.
    Jang EH; Kim HK; Park CS; Kang JH
    Drug Metab Pharmacokinet; 2010; 25(4):392-7. PubMed ID: 20814161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.
    Jin HE; Hong SS; Choi MK; Maeng HJ; Kim DD; Chung SJ; Shim CK
    Pharm Res; 2009 Mar; 26(3):549-59. PubMed ID: 19002567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic uptake and excretion of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel if channel inhibitor, in rats and humans.
    Umehara K; Iwai M; Adachi Y; Iwatsubo T; Usui T; Kamimura H
    Drug Metab Dispos; 2008 Jun; 36(6):1030-8. PubMed ID: 18332079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity.
    Tu M; Sun S; Wang K; Peng X; Wang R; Li L; Zeng S; Zhou H; Jiang H
    Toxicology; 2013 Sep; 311(3):225-30. PubMed ID: 23831208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys.
    Morse BL; MacGuire JG; Marino AM; Zhao Y; Fox M; Zhang Y; Shen H; Griffith Humphreys W; Marathe P; Lai Y
    AAPS J; 2017 Nov; 19(6):1878-1889. PubMed ID: 29019117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.
    Chen L; Shu Y; Liang X; Chen EC; Yee SW; Zur AA; Li S; Xu L; Keshari KR; Lin MJ; Chien HC; Zhang Y; Morrissey KM; Liu J; Ostrem J; Younger NS; Kurhanewicz J; Shokat KM; Ashrafi K; Giacomini KM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9983-8. PubMed ID: 24961373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats.
    Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
    Xenobiotica; 2007 Aug; 37(8):818-31. PubMed ID: 17701831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk.
    Ito K; Sjöstedt N; Malinen MM; Guo C; Brouwer KLR
    J Pharmacol Exp Ther; 2020 May; 373(2):261-268. PubMed ID: 32127372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys.
    Shen H; Su H; Liu T; Yao M; Mintier G; Li L; Fancher RM; Iyer R; Marathe P; Lai Y; Rodrigues AD
    J Pharmacol Exp Ther; 2015 May; 353(2):380-91. PubMed ID: 25740896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability and Heritability of Thiamine Pharmacokinetics With Focus on OCT1 Effects on Membrane Transport and Pharmacokinetics in Humans.
    Jensen O; Matthaei J; Blome F; Schwab M; Tzvetkov MV; Brockmöller J
    Clin Pharmacol Ther; 2020 Mar; 107(3):628-638. PubMed ID: 31593619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in human.
    Salphati L; Pang J; Plise EG; Lee LB; Olivero AG; Prior WW; Sampath D; Wong S; Zhang X
    Drug Metab Dispos; 2012 Sep; 40(9):1785-96. PubMed ID: 22696419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
    Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
    Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats.
    Shitara Y; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Dispos; 2009 Jun; 37(6):1172-8. PubMed ID: 19282398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.